vs
Oil-Dri Corp of America（ODC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Oil-Dri Corp of America的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$120.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 12.8%，领先371.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -5.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.8%）
美国Oil-Dri公司是专业吸附剂及黏土基产品生产商，主营工业溢油清理吸附材料、猫砂等宠物护理产品、农业土壤改良剂及运动场场地调理材料，客户覆盖北美及全球多个商业领域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ODC vs RIGL — 直观对比
营收规模更大
ODC
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出27.0%
-5.8%
净利率更高
RIGL
高出371.2%
12.8%
两年增速更快
RIGL
近两年复合增速
6.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.5M | $69.8M |
| 净利润 | $15.5M | $268.1M |
| 毛利率 | 29.5% | 91.5% |
| 营业利润率 | 14.1% | 33.2% |
| 净利率 | 12.8% | 384.0% |
| 营收同比 | -5.8% | 21.2% |
| 净利润同比 | -5.6% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ODCRIGL
| Q4 25 | $120.5M | $69.8M | ||
| Q3 25 | $125.2M | $69.5M | ||
| Q2 25 | $115.5M | $101.7M | ||
| Q1 25 | $116.9M | $53.3M | ||
| Q4 24 | $127.9M | $57.6M | ||
| Q3 24 | $113.7M | $55.3M | ||
| Q2 24 | $106.8M | $36.8M | ||
| Q1 24 | $105.7M | $29.5M |
净利润ODCRIGL
| Q4 25 | $15.5M | $268.1M | ||
| Q3 25 | $13.1M | $27.9M | ||
| Q2 25 | $11.6M | $59.6M | ||
| Q1 25 | $12.9M | $11.4M | ||
| Q4 24 | $16.4M | $14.3M | ||
| Q3 24 | $8.5M | $12.4M | ||
| Q2 24 | $7.8M | $-1.0M | ||
| Q1 24 | $12.4M | $-8.2M |
毛利率ODCRIGL
| Q4 25 | 29.5% | 91.5% | ||
| Q3 25 | 27.8% | 93.2% | ||
| Q2 25 | 28.6% | 95.6% | ||
| Q1 25 | 29.5% | 91.7% | ||
| Q4 24 | 31.9% | 89.9% | ||
| Q3 24 | 29.0% | 85.5% | ||
| Q2 24 | 28.2% | 92.4% | ||
| Q1 24 | 29.3% | 93.1% |
营业利润率ODCRIGL
| Q4 25 | 14.1% | 33.2% | ||
| Q3 25 | 12.5% | 40.9% | ||
| Q2 25 | 12.0% | 60.1% | ||
| Q1 25 | 15.0% | 23.9% | ||
| Q4 24 | 16.6% | 28.9% | ||
| Q3 24 | 11.3% | 25.4% | ||
| Q2 24 | 9.8% | 1.2% | ||
| Q1 24 | 14.4% | -23.6% |
净利率ODCRIGL
| Q4 25 | 12.8% | 384.0% | ||
| Q3 25 | 10.4% | 40.2% | ||
| Q2 25 | 10.1% | 58.6% | ||
| Q1 25 | 11.1% | 21.5% | ||
| Q4 24 | 12.8% | 24.9% | ||
| Q3 24 | 7.5% | 22.5% | ||
| Q2 24 | 7.3% | -2.8% | ||
| Q1 24 | 11.7% | -27.9% |
每股收益（稀释后）ODCRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.4M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $266.5M | $391.5M |
| 总资产 | $380.7M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ODCRIGL
| Q4 25 | $42.4M | $155.0M | ||
| Q3 25 | $50.5M | $137.1M | ||
| Q2 25 | $36.5M | $108.4M | ||
| Q1 25 | $22.6M | $77.1M | ||
| Q4 24 | $12.5M | $77.3M | ||
| Q3 24 | $23.5M | $61.1M | ||
| Q2 24 | $46.8M | $49.1M | ||
| Q1 24 | $27.8M | $49.5M |
总债务ODCRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ODCRIGL
| Q4 25 | $266.5M | $391.5M | ||
| Q3 25 | $259.1M | $117.6M | ||
| Q2 25 | $246.9M | $81.9M | ||
| Q1 25 | $235.9M | $18.6M | ||
| Q4 24 | $224.0M | $3.3M | ||
| Q3 24 | $210.6M | $-14.6M | ||
| Q2 24 | $202.9M | $-29.9M | ||
| Q1 24 | $196.0M | $-31.7M |
总资产ODCRIGL
| Q4 25 | $380.7M | $513.6M | ||
| Q3 25 | $391.7M | $242.5M | ||
| Q2 25 | $369.5M | $206.7M | ||
| Q1 25 | $353.7M | $176.0M | ||
| Q4 24 | $350.2M | $164.0M | ||
| Q3 24 | $354.6M | $139.4M | ||
| Q2 24 | $319.2M | $128.4M | ||
| Q1 24 | $296.2M | $126.5M |
负债/权益比ODCRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $1.3M | — |
| 自由现金流率自由现金流/营收 | 1.1% | — |
| 资本支出强度资本支出/营收 | 7.5% | — |
| 现金转化率经营现金流/净利润 | 0.67× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $50.8M | — |
8季度趋势，按日历期对齐
经营现金流ODCRIGL
| Q4 25 | $10.3M | $22.0M | ||
| Q3 25 | $25.2M | $24.0M | ||
| Q2 25 | $22.7M | $30.5M | ||
| Q1 25 | $21.4M | $-893.0K | ||
| Q4 24 | $10.9M | $14.5M | ||
| Q3 24 | $23.4M | $21.7M | ||
| Q2 24 | $19.0M | $302.0K | ||
| Q1 24 | $9.4M | $-5.0M |
自由现金流ODCRIGL
| Q4 25 | $1.3M | — | ||
| Q3 25 | $17.1M | — | ||
| Q2 25 | $16.0M | — | ||
| Q1 25 | $16.4M | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $15.1M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $1.9M | — |
自由现金流率ODCRIGL
| Q4 25 | 1.1% | — | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 13.8% | — | ||
| Q1 25 | 14.0% | — | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 10.1% | — | ||
| Q1 24 | 1.8% | — |
资本支出强度ODCRIGL
| Q4 25 | 7.5% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 7.7% | — | ||
| Q1 24 | 7.1% | — |
现金转化率ODCRIGL
| Q4 25 | 0.67× | 0.08× | ||
| Q3 25 | 1.93× | 0.86× | ||
| Q2 25 | 1.95× | 0.51× | ||
| Q1 25 | 1.66× | -0.08× | ||
| Q4 24 | 0.67× | 1.01× | ||
| Q3 24 | 2.74× | 1.75× | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 0.76× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ODC
| Cat Litter | $64.6M | 54% |
| Fluids Purification | $26.7M | 22% |
| Agriculturaland Horticultural | $12.9M | 11% |
| Industrialand Sports | $11.6M | 10% |
| Animal Healthand Nutrition | $4.7M | 4% |
RIGL
暂无分部数据
